Profitability:
Adjusted margins and earnings improved despite revenue contraction, reflecting disciplined cost management and a focus on margin preservation. Guidance and recent quarters indicate sustained emphasis on mid‑20s adjusted EBITDA margins.
Healthy Cash Flow:
Operating cash flow and unlevered free cash flow were solid in recent periods, providing flexibility to invest through the downturn. Trailing cash generation underscores resilience even as GAAP results include non‑cash impairments.
Strong Market Position & Advantage:
The company is widely recognized as a leader in healthcare commercial intelligence with thousands of customers and deep datasets anchoring demand in its niche. Ongoing integrations and product enhancements aim to reinforce positioning with enterprise buyers.
